Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mckesson Corp (MCK)

Mckesson Corp (MCK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,920,934
  • Shares Outstanding, K 176,930
  • Annual Sales, $ 214,319 M
  • Annual Income, $ 34,000 K
  • 60-Month Beta 0.88
  • Price/Sales 0.11
  • Price/Cash Flow 4.22
  • Price/Book 3.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.13
  • Number of Estimates 8
  • High Estimate 4.27
  • Low Estimate 4.06
  • Prior Year 3.69
  • Growth Rate Est. (year over year) +11.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
112.60 +17.30%
on 03/16/20
147.11 -10.22%
on 03/18/20
-9.41 (-6.65%)
since 03/06/20
3-Month
112.60 +17.30%
on 03/16/20
172.18 -23.29%
on 02/21/20
-5.77 (-4.19%)
since 01/07/20
52-Week
111.71 +18.23%
on 04/17/19
172.18 -23.29%
on 02/21/20
+15.38 (+13.18%)
since 04/05/19

Most Recent Stories

More News
Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.

SYK : 165.79 (+0.08%)
MCK : 132.08 (-2.31%)
MMSI : 32.98 (-1.52%)
COO : 292.64 (-1.36%)
Here's Why You Should Hold on to Avanos Medical Stock Now

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

MCK : 132.08 (-2.31%)
MMSI : 32.98 (-1.52%)
COO : 292.64 (-1.36%)
AVNS : 25.95 (+0.82%)
MCK vs. COO: Which Stock Is the Better Value Option?

MCK vs. COO: Which Stock Is the Better Value Option?

MCK : 132.08 (-2.31%)
COO : 292.64 (-1.36%)
Coronavirus Hits S&P 500: 4 MedTech Stocks That Fared Better

Here are a few MedTech companies which have outperformed the S&P 500 index in the past two months.

CAH : 47.88 (-2.98%)
MCK : 132.08 (-2.31%)
TMO : 297.00 (-2.30%)
IDXX : 251.74 (-1.06%)
Here's Why You Should Add Integer Holdings to Your Portfolio

Integer Holdings (ITGR) continues to gain traction from solid presence in the broader MedTech space and portfolio management.

MCK : 132.08 (-2.31%)
MMSI : 32.98 (-1.52%)
COO : 292.64 (-1.36%)
ITGR : 60.13 (+2.98%)
Should iShares Morningstar Mid-Cap Value ETF (JKI) Be on Your Investing Radar?

Style Box ETF report for JKI

JKI : 108.99 (+1.91%)
MCK : 132.08 (-2.31%)
KR : 31.86 (-2.36%)
ES : 79.78 (-2.81%)
VOE : 83.03 (+1.27%)
IWS : 65.57 (+1.44%)
The Global Home Healthcare Market is expected to grow from USD 216,920.28 Million in 2018 to USD 364,389.47 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.69%

Reportlinker.com announces the release of the report "Global Home Healthcare Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" - https://www.reportlinker.com/p05871815/?utm_source=GNW...

AFAM : 56.00 (+1.91%)
MCK : 132.08 (-2.31%)
OMRNY : 52.7500 (+1.09%)
US Faces Biggest Healthcare Challenge -- And It's Not COVID-19

Globally, the world is focused on COVID-19, but the real challenge facing the healthcare industry may be something much less obvious: accessibility and affordable. Runaway prescription costs and access...

AMZN : 2,011.60 (+0.70%)
MCK : 132.08 (-2.31%)
TDOC : 141.25 (-5.91%)
CVS : 57.05 (+1.48%)
MEDS : 5.91 (-3.11%)
Can Retail Pharmacy USA Aid Walgreen Boots' (WBA) Q2 Earnings?

Solid prescription volume growth and brand inflation anticipated to have aided Walgreen Boots' (WBA) Retail Pharmacy USA performance in Q2.

UNH : 244.44 (-1.57%)
JNJ : 137.45 (-1.65%)
MCK : 132.08 (-2.31%)
WBA : 42.81 (+0.42%)
Here's Why You Should Invest in McKesson (MCK) Stock Now

McKesson (MCK) continues to gain traction from its multi-year strategic growth initiative and distribution solutions segment.

ABC : 87.20 (+1.05%)
MCK : 132.08 (-2.31%)
COO : 292.64 (-1.36%)
PDCO : 14.05 (+7.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade MCK with:

Business Summary

McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare...

See More

Key Turning Points

2nd Resistance Point 140.82
1st Resistance Point 138.01
Last Price 132.08
1st Support Level 130.26
2nd Support Level 125.32

See More

52-Week High 172.18
Fibonacci 61.8% 149.08
Fibonacci 50% 141.94
Fibonacci 38.2% 134.81
Last Price 132.08
52-Week Low 111.71

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar